amifostine anhydrous has been researched along with Dysuria in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Dysuria: Painful URINATION. It is often associated with infections of the lower URINARY TRACT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Grade 2 proctitis was noted in 18." | 1.38 | Postoperative pelvic hypofractionated accelerated radiotherapy with cytoprotection (HypoARC) for high-risk or recurrent prostate cancer. ( Abatzoglou, I; Koukourakis, MI; Panteliadou, M; Papadopoulou, A; Sismanidou, K; Touloupidis, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koukourakis, MI | 1 |
| Papadopoulou, A | 1 |
| Abatzoglou, I | 1 |
| Panteliadou, M | 1 |
| Sismanidou, K | 1 |
| Touloupidis, S | 1 |
1 other study available for amifostine anhydrous and Dysuria
| Article | Year |
|---|---|
Postoperative pelvic hypofractionated accelerated radiotherapy with cytoprotection (HypoARC) for high-risk or recurrent prostate cancer.
Topics: Aged; Amifostine; Carcinoma; Cytoprotection; Diarrhea; Dysuria; Humans; Male; Middle Aged; Proctitis | 2012 |